-+ 0.00%
-+ 0.00%
-+ 0.00%

JP Morgan Maintains Neutral on HCA Healthcare, Lowers Price Target to $425

Benzinga·08/20/2026 18:03:25
Listen to the news
JP Morgan analyst Benjamin Rossi maintains HCA Healthcare (NYSE:HCA) with a Neutral and lowers the price target from $490 to $425.